Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9172047 | 0.85 | TRPA1 (0.33) | TRPA1ALDH1A1TSHR | |
| SCHEMBL9172056 | 0.85 | CYP4F2 (0.39) | TRPA1ALDH1A1TSHRCES2CES1 | |
| SCHEMBL3373171 | 0.79 | SNCA (0.36) | TRPA1ALDH1A1TSHRCES2CES1 | |
| SCHEMBL3518446 | 0.77 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR | |
| SCHEMBL17151870 | 0.77 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR | |
| SCHEMBL11842351 | 0.77 | CYP4F2 (0.36) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL6422600 | 0.77 | TRPA1 (0.35) | TRPA1ALDH1A1TSHR | |
| SCHEMBL2118677 | 0.77 | DHFR (0.42) | TRPA1ALDH1A1TSHRCES2CES1 | |
| SCHEMBL6629667 | 0.77 | TRPA1 (0.35) | TRPA1ALDH1A1TSHRCYP4F2CYP4A11 | |
| SCHEMBL2009460 | 0.77 | ALDH1A1 (0.35) | TRPA1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| EP-4043091-A1 | INTERFACIAL POLYMERIZATION METHOD FOR PREPARING MEMBRANES | Universiteit Twente (NL) | 2022-08-17 | — | — | EP | disclosed |
| EP-3124490-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | Sigma-Aldrich Co. LLC (US) | 2017-02-01 | — | — | EP | disclosed |
| EP-3124490-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | Sigma-Aldrich Co. LLC (US) | 2017-02-01 | — | — | EP | disclosed |
| EP-2114969-B1 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA ALDRICH CO LLC (US) | 2016-06-29 | — | — | EP | disclosed |
| EP-2114969-B1 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA ALDRICH CO LLC (US) | 2016-06-29 | — | — | EP | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-04-05 | — | — | US | disclosed |
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | SIGMA-ALDRICH CO. NEWCO INC. | 2008-09-04 | — | — | US | disclosed |
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | SIGMA-ALDRICH CO. NEWCO INC. | 2008-09-04 | — | — | US | disclosed |
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | SIGMA-ALDRICH CO. NEWCO INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008095069-A2 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. (US) | 2008-08-07 | — | — | WO | disclosed |
| WO-2008095069-A2 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-5593980-A | ANTIARTHRITIC AGENTS FOR ADMINISTERING | THE UPJOHN COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5500417-A | ANTIARTHRITIC | THE UPJOHN COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| EP-0661978-A1 | ARYLMETHYLPHOSPHONATES AND PHOSPHONIC ACIDS USEFUL AS ANTI-INFLAMMATORY AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| WO-1994007501-A1 | ARYLMETHYLPHOSPHONATES AND PHOSPHONIC ACIDS USEFUL AS ANTI-INFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1994-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | PUF60, POLI, PARG | TRPA1 3485/4885ALDH1A1 4720/4885TSHR 4659/4885 |
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | PUF60, POLI, PARG | TRPA1 3485/4885ALDH1A1 4720/4885TSHR 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.